Skip to content

Application of intravenous injection followed by pump injection of lidocaine in accelerating postoperative rehabilitation of patients with stoma restoration

Application of intravenous injection followed by pump injection of lidocaine in accelerating postoperative rehabilitation of patients with stoma restoration

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042532
Enrollment
Unknown
Registered
2021-01-23
Start date
2021-01-30
Completion date
Unknown
Last updated
2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of lidocaine on postoperative recovery of intestinal function

Interventions

lidocaine group:1.5mg/kg (ideal body weight) of lidocaine (total dose not to exceed 100 mg) was given by slow push (approximately 30 seconds) before induction of anesthesia, followed by continuous pum
control group:saline given at the same dose and rate at the corresponding time point

Sponsors

The First Affiliated Hospital of Naval Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients over 18 years old and under 75 years old; 2. Stoma can be used for patients undergoing elective operation; 3. Patients with BMI of 18-30kg / m2.

Exclusion criteria

Exclusion criteria: 1. Patients with gastrointestinal dysfunction before operation; 2. Patients with a history of mental illness or uncontrollable seizures; 3. Patients who are allergic to or contraindicated to the drugs used in this study; 4. Patients with history of alcohol or drug abuse or long-term use of opioids; 5. Patients with severe cardiopulmonary dysfunction, such as severe arrhythmia, heart block, heart failure, hypertrophic cardiomyopathy, dilated cardiomyopathy, pulmonary heart disease and severe valve disease, respiratory failure 6. Patients with severe liver and kidney dysfunction; 7. Patients who are using drugs with incompatibility with lidocaine, such as sodium thiopental, mannitol, sodium nitroprusside, phenobarbital, etc.; 8. Patients who cannot cooperate with the study for any reason; 9. Patients who used other trial drugs or were participating in other clinical trials in the first three months of the study; 10. Patients with severe surgical complications.

Design outcomes

Primary

MeasureTime frame
First exhaust time;

Secondary

MeasureTime frame
Intraoperative opioid dosage;Time for extubation of endotracheal tube;The VAS score of leaving the recovery room;Postoperative Riker score;Opioid dosage within 48 hours after operation;VAS score 24 hours after operation;VAS score 48 hours after operation;First defecation time;First drinking and eating time;Postoperative hospital stay;total duration of hospitalization;

Countries

China

Contacts

Public ContactLulong Bo

The First Affiliated Hospital of Naval Medical University

nbastars@126.com+86 21-31161840

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026